• Japanese
  • Korean
Cover Image

Global Markets for Neurosurgical Products: Forecasts Through 2018

Abstract

Overview

image1

Common conditions necessitating the use of neurosurgical products include hydrocephalus, aneurysms, arteriovenous malformations (AVMs), and pituitary and intracranial tumors. Intracranial shunts are often used to treat hydrocephalus. Aneurysms and AVMs may be treated using surgical clips or, increasingly, embolization products that may be deployed during endovascular procedures. Pituitary and intracranial tumors may be removed during open surgery, endoscopic surgery, or stereotactic radiosurgery (SRS).


This in-depth report analyzes the trends and opportunities in the global neurosurgical products market and provides details on the current and future outlook for the patient populations, procedures, and competitors driving growth and innovation.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1.1 Regional Analysis
  • 1.2 Product Analysis
    • 1.2.1 Stereotactic Radiosurgery
    • 1.2.2 Embolization Products
    • 1.2.3 Intracranial Shunts
    • 1.2.4 Neurosurgical Endoscopes
    • 1.2.5 Aneurysm and AVM Clips
  • Exhibit 1-1: Neurosurgical Products, Global Market Forecast by Region, 2010-2018
  • Exhibit 1-2: Neurosurgical Products, Global Market Forecast by Product Segment, 2010-2018
  • Exhibit 1-3: Factors Driving the U.S. Market, 2010-2018
  • Exhibit 1-4: U.S. Market Forecast by Product Type, 2010-2018
  • Exhibit 1-5: Factors Driving International Markets, 2010-2018
  • Exhibit 1-6: International Market Forecast by Product, 2010-2018

2. OVERVIEW

  • 2.1 Hydrocephalus
    • 2.1.1 Causes of Hydrocephalus
    • 2.1.2 Types of Hydrocephalus
    • 2.1.3 Global Incidence by Region
      • 2.1.3.1 Pediatric Hydrocephalus
      • 2.1.3.2 Adult Hydrocephalus
  • 2.2 Aneurysm and Arteriovenous Malformation
    • 2.2.1 Aneurysms
    • 2.2.2 AVMs
    • 2.2.3 Prevalence of Aneurysm and AVM
  • 2.3 Pituitary, Skull Base and Intracranial Tumors
  • Exhibit 2-1: Major Indications for Intracranial, Neurovascular, and Skull Base Procedures
  • Exhibit 2-2: Causes and Types of Hydrocephalus
  • Exhibit 2-3: Selected Studies of the Incidence and Prevalence of Hydrocephalus
  • Exhibit 2-4: Selected Studies of the Incidence & Prevalence of Aneurysm & AVM
  • Exhibit 2-5: Types of Skull Base and Intracranial Tumors
  • Exhibit 2-6: Selected Studies of the Incidence and Prevalence of Pituitary, Skull Base and Intracranial Tumors

3. NEUROSURGICAL PRODUCTS FOR OPEN SURGERY

  • 3.1 Intracranial Shunts
    • 3.1.1 The Procedure
    • 3.1.2 Benefits and Challenges of Intracranial Shunts
    • 3.1.3 Product Types
    • 3.1.4 Products and Companies
    • 3.1.5 Emerging Trends
  • 3.2 Aneurysm, AVM, and Subarachnoid Hemorrhage Devices
    • 3.2.1 Aneurysm and AVM Clips
      • 3.2.1.1 Types of Clips
      • 3.2.1.2 Products and Companies
  • Exhibit 3-1: Major Indications for Intracranial Shunts
  • Exhibit 3-2: Benefits and Challenges of Intracranial Shunts
  • Exhibit 3-3: Common Configurations of Shunt Systems
  • Exhibit 3-4: Types of Intracranial Shunt Systems
  • Exhibit 3-5: Valves and Other Shunt Products
  • Exhibit 3-6: Selected Shunt Systems and Products in 2012
  • Exhibit 3-7: Methods of Treating Aneurysm, AVM, and SAH
  • Exhibit 3-8: Advantages and Disadvantages of Aneurysm/AVM Clips
  • Exhibit 3-9: Features of Aneurysm and AVM Clips
  • Exhibit 3-10: Selected Aneurysm and AVM Clips and Products in 2012

4. NEUROVASCULAR AND MINIMALLY INVASIVE PRODUCTS

  • 4.1 Embolization Products
    • 4.1.1 Endovascular Coils
      • 4.1.1.1 Types of Coils
      • 4.1.1.2 Emerging Trends
    • 4.1.2 AVM Embolization Products
    • 4.1.3 Products and Companies
  • 4.2 Endoscopic Neurosurgery
    • 4.2.1 Endoscopic Transsphenoidal Neurosurgery
    • 4.2.2 Endoscopic Third Ventriculostomy
    • 4.2.3 Endoscopic Approaches for Acoustic Neuroma and Trigeminal Neuralgia
    • 4.2.4 Other Endoscopic Approaches
    • 4.2.5 Limitations of Endoscopic Techniques
    • 4.2.6 Current Endoscopes
    • 4.2.7 Products and Companies
  • 4.3 Stereotactic Radiosurgical Systems
    • 4.3.1 Gamma Irradiation Sytems
    • 4.3.2 Linac Systems
    • 4.3.3 Particle Beam Radiation Therapy Systems
    • 4.3.4 Products and Companies
  • Exhibit 4-1: The Advantages and Disadvantages of Open Neurosurgery
  • Exhibit 4-2: Types of Products Used in Minimally Invasive Neurosurgery
  • Exhibit 4-3: Major Limitations of MI Products and Techniques
  • Exhibit 4-4: Endovascular Methods of Treating Aneurysms
  • Exhibit 4-5: Selected Studies of Endovascular Coiling
  • Exhibit 4-6: Selected Endovascular Coiling Products in 2012
  • Exhibit 4-7: Endoscopic Neurosurgery, Techniques and Conditions
  • Exhibit 4-8: Features of Neurosurgical Endoscopes
  • Exhibit 4-9: Selected Neurosurgical Endoscopes in 2012
  • Exhibit 4-10: Types of Stereotactic Radiosurgery Systems in 2012
  • Exhibit 4-11: Selected Studies of Gamma Irradiation Radiosurgery for Epilepsy and Movement Disorders
  • Exhibit 4-12: Results of Gamma Irradiation Radiosurgery for Epilepsy, PD, & ET
  • Exhibit 4-13: Features of Neurosurgical Linear Accelerator Systems
  • Exhibit 4-14: Features of Particle Beam Radiation Therapy Systems
  • Exhibit 4-15: Advantages and Disadvantages of Proton-Beam Radiation Therapy
  • Exhibit 4-16: Stereotactic Radiosurgery Systems, Companies and Products in 2012

5. PROCEDURES AND PRODUCT MARKETS

  • 5.1 Intracranial Shunts
    • 5.1.1 Intracranial Shunts - Procedure Forecasts
      • 5.1.1.1 U.S. Procedure Forecast
      • 5.1.1.2 European Procedure Forecast
      • 5.1.1.3 AP & ROW Procedure Forecast
    • 5.1.2 Intracranial Shunts - Market Analysis
      • 5.1.2.1 U.S. Market Analysis
      • 5.1.2.2 European Market Forecast
      • 5.1.2.3 AP & ROW Market Forecast
      • 5.1.2.4 Company Analysis
  • 5.2 Aneurysm and AVM Clips
    • 5.2.1 Aneurysm and AVM Clips - Procedure Forecasts
      • 5.2.1.1 U.S. Procedure Forecast
      • 5.2.1.2 European Procedure Forecast
      • 5.2.1.3 AP & ROW Procedure Forecast
    • 5.2.2 Aneurysm and AVM Clips - Market Analysis
      • 5.2.2.1 U.S. Market Analysis
      • 5.2.2.2 European Market Forecast
      • 5.2.2.3 AP & ROW Market Forecast
      • 5.2.2.4 Company Analysis
  • 5.3 Embolization Products
  • 5.4 Embolization Products - Procedure Forecasts
    • 5.4.1 U.S. Procedure Forecast
    • 5.4.2 European Procedure Forecast
    • 5.4.3 AP & ROW Procedure Forecast
    • 5.4.4 Embolization Products - Market Analysis
      • 5.4.4.1 U.S. Market Analysis
      • 5.4.4.2 European Market Analysis
      • 5.4.4.3 AP & ROW Market Analysis
      • 5.4.4.4 Company Analysis
  • 5.5 Neurosurgical Endoscopes
    • 5.5.1 Procedure Forecasts
      • 5.5.1.1 U.S. Procedure Forecast
      • 5.5.1.2 European Procedure Forecast
      • 5.5.1.3 AP & ROW Procedure Forecast
    • 5.5.2 Market Analysis
      • 5.5.2.1 U.S. Market Analysis
      • 5.5.2.2 International Market Analysis
      • 5.5.2.3 Company Analysis
  • 5.6 Stereotactic Radiosurgery Systems
    • 5.6.1 Procedure Forecasts
      • 5.6.1.1 U.S. Procedure Forecast
      • 5.6.1.2 European Procedure Forecast
      • 5.6.1.3 AP & ROW Procedure Forecast
    • 5.6.2 Market Analysis
      • 5.6.2.1 U.S. Market Analysis
      • 5.6.2.2 European Market Analysis
      • 5.6.2.3 AP & ROW Market Analysis
      • 5.6.2.4 Company Analysis
  • Exhibit 5-1: Neurosurgical Products, Global Forecast by Product Segment, 2010-2018
  • Exhibit 5-2: Neurosurgical Products, Global Forecast by Region, 2010-2018
  • Exhibit 5-3: Intracranial Shunts, Global Procedure Forecast, 2010-2018
  • Exhibit 5-4: U.S. Procedure Forecast, New Shunt Placements in Pediatric Patients, 2010-2018
  • Exhibit 5-5: U.S. Procedure Forecast, New Shunt Placements in Adult Patients, 2010-2018
  • Exhibit 5-6: New Shunt Placements in Pediatric and Adult Patients in the U.S., 2010-2018
  • Exhibit 5-7: U.S. Procedure Forecast, New Shunt Placements and Revision Surgeries, 2010-2018
  • Exhibit 5-8: European Procedure Forecast, New Shunt Placements in Pediatric Patients, 2010-2018
  • Exhibit 5-9: European Procedure Forecast, New Shunt Placements in Adult Patients, 2010-2018
  • Exhibit 5-10: European Procedure Forecast, New Shunt Placements and Revision Surgeries, 2010-2018
  • Exhibit 5-11: AP & ROW Procedure Forecast, New Shunt Placements in Pediatric Patients, 2010-2018
  • Exhibit 5-12: European Procedure Forecast, New Shunt Placements in Adult Patients, 2010-2018
  • Exhibit 5-13: AP & ROW Procedure Forecast, New Shunt Placements and Revision Surgeries, 2010-2018
  • Exhibit 5-14: Global Market Forecast for Hydrocephalus Shunt Products, 2010-2018
  • Exhibit 5-15: U.S. Forecast, New and Replacement Units and Accessories, 2010-2018
  • Exhibit 5-16: U.S. Market Forecast, Types of Shunt Systems, 2010-2018
  • Exhibit 5-17: U.S. Market Forecast for Hydrocephalus Shunt Systems, 2010-2018
  • Exhibit 5-18: European Forecast, New and Replacement Units and Accessories, 2010-2018
  • Exhibit 5-19: European Market Forecast, Types of Shunt Systems, 2010-2018
  • Exhibit 5-20: European Market Forecast for Hydrocephalus Shunt Systems, 2010-2018
  • Exhibit 5-21: AP & ROW Forecast, New and Replacement Units and Accessories, 2010-2018
  • Exhibit 5-22: AP & ROW Market Forecast, Types of Shunt Systems, 2010-2018
  • Exhibit 5-23: AP & ROW Market Forecast for Hydrocephalus Shunt Systems, 2010-2018
  • Exhibit 5-24: Intracranial Shunt Suppliers and Market Shares in 2011
  • Exhibit 5-25: Surgical Clipping Procedures for Aneurysm and AVM, Global Forecast, 2010-2018
  • Exhibit 5-26: Surgical Clipping Procedures for Aneurysm and AVM, U.S. Forecast, 2010-2018
  • Exhibit 5-27: Surgical Clipping Procedures for Aneurysm and AVM, European Forecast, 2010-2018
  • Exhibit 5-28: Surgical Clipping Procedures for Aneurysm and AVM, AP & ROW Forecast, 2010-2018
  • Exhibit 5-29: Global Market Forecast for Aneurysm and AVM Clips and Accessories, 2010-2018
  • Exhibit 5-30: Aneurysm and AVM Clips, U.S. Unit Forecast, 2010-2018
  • Exhibit 5-31: Aneurysm and AVM Clips and Accessories, U.S. Market Forecast, 2010-2018
  • Exhibit 5-32: Aneurysm and AVM Clips, European Unit Forecast, 2010-2018
  • Exhibit 5-33: Aneurysm and AVM Clips and Accessories, European Market Forecast, 2010-2018
  • Exhibit 5-34: Aneurysm and AVM Clips, AP & ROW Unit Forecast, 2010-2018
  • Exhibit 5-35: Aneurysm and AVM Clips and Accessories, AP & ROW Market Forecast, 2010-2018
  • Exhibit 5-36: Aneurysm & AVM Suppliers and Market Shares in 2011
  • Exhibit 5-37: Global Procedure Forecast for Embolization Products, 2010-2018
  • Exhibit 5-38: U.S. Procedure Forecast, Embolization Products, 2010-2018
  • Exhibit 5-39: European Procedure Forecast, Embolization Products, 2010-2018
  • Exhibit 5-40: AP & ROW Procedure Forecast, Embolization Products, 2010-2018
  • Exhibit 5-41: Aneurysm and AVM Embolization Products, Global Market Forecast, 2010-2018
  • Exhibit 5-42: Aneurysm and AVM Embolization Products, U.S. Market Forecast, 2010-2018
  • Exhibit 5-43: Aneurysm and AVM Embolization Products, European Market Forecast, 2010-2018
  • Exhibit 5-44: Aneurysm and AVM Embolization Products, AP & ROW Market Forecast, 2010-2018
  • Exhibit 5-45: Embolization Product Revenues and Market Shares in 2011
  • Exhibit 5-46: Neurosurgical Endoscopy, Global Procedure Forecast, 2010-2018
  • Exhibit 5-47: Factors Driving & Limiting Neuroendoscopy in the Global Market
  • Exhibit 5-48: Endoscopic Neurosurgeries in the U.S., Procedure Forecast, 2010-2018
  • Exhibit 5-49: Endoscopic Neurosurgeries by Type, U.S. Procedure Forecast, 2010-2018
  • Exhibit 5-50: Endoscopic Neurosurgeries in Europe, Procedure Forecast, 2010-2018
  • Exhibit 5-51: Endoscopic Neurosurgeries by Type, European Procedure Forecast, 2010-2018
  • Exhibit 5-52: Endoscopic Neurosurgeries in AP & ROW, Procedure Forecast, 2010-2018
  • Exhibit 5-53: Endoscopic Neurosurgeries by Type, AP & ROW Procedure Forecast, 2010-2018
  • Exhibit 5-54: Neurosurgical Endoscopy, Global Market Forecast, 2010-2018
  • Exhibit 5-55: Neurosurgical Endoscopy Products, U.S. Market Forecast, 2010-2018
  • Exhibit 5-56: Neurosurgical Endoscopy Products, International Market Forecast, 2010-2018
  • Exhibit 5-57: Neuroendoscopy Products, Suppliers and Market Shares in 2011
  • Exhibit 5-58: SRS Procedures for Intracranial Applications, Global Procedure Forecast, 2010-2018
  • Exhibit 5-59: SRS Procedures for Intracranial Applications, U.S. Procedure Forecast, 2010-2018
  • Exhibit 5-60: SRS Procedures for Intracranial Applications, European Procedure Forecast, 2010-2018
  • Exhibit 5-61: SRS Procedures for Intracranial Applications, AP & ROW Procedure Forecast, 2010-2018
  • Exhibit 5-62: Intracranial SRS Products, Global Market Forecast, 2010-2018
  • Exhibit 5-63: Intracranial SRS Products, U.S. Market Forecast, 2010-2018
  • Exhibit 5-64: Intracranial SRS Products, European Market Forecast, 2010-2018
  • Exhibit 5-65: Intracranial SRS Products, AP & ROW Market Forecast, 2010-2018
  • Exhibit 5-66: Intracranial SRS, Suppliers and Market Shares in 2011

6. COMPANY PROFILES

  • 6.1 Accuray
  • 6.2 Aesculap (B. Braun)
  • 6.3 Elekta AB
  • 6.4 Covidien
  • 6.5 Integra Lifesciences
  • 6.6 Johnson & Johnson
  • 6.7 Karl Storz
  • 6.8 Medtronic
  • 6.9 Stryker Neurovascular
  • 6.10 Terumo

Companies

  • Accuray
  • Aesculap (B. Braun)
  • Elekta AB
  • Covidien
  • Integra Lifesciences
  • Johnson & Johnson
  • Karl Storz
  • Medtronic
  • Stryker Neurovascular
  • Terumo
Show More
Pricing